Correlation of gut microbiota metabolite trimethylamine N-oxide with inflammatory levels and osteoporosis in patients with diabetic nephropathy

doi:10.4239/wjd.v16.i11.109919

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

This Article

(41)

(54)

(0)

(13)

(779)

(2)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Diabetes. Nov 15, 2025; 16(11): 109919
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.109919

Full Size Figure Download Figure

Figure 1 Statistical comparison of gastrointestinal flora abundance between the two groups of patients. A: Comparison of Chaol index; B: ACE index comparison; C: For the Shannon index comparison; D: Comparison of Simpson index. T2DM: Type 2 diabetes mellitus; DN: Diabetic nephropathy.

Citation: Pan ZL, Li MQ, Zhang J, Xue LY, Shi YP. Correlation of gut microbiota metabolite trimethylamine N-oxide with inflammatory levels and osteoporosis in patients with diabetic nephropathy. World J Diabetes 2025; 16(11): 109919
URL: https://www.wjgnet.com/1948-9358/full/v16/i11/109919.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i11.109919

Pan ZL, Li MQ, Zhang J, Xue LY, Shi YP. Correlation of gut microbiota metabolite trimethylamine N-oxide with inflammatory levels and osteoporosis in patients with diabetic nephropathy. World J Diabetes 2025; 16(11): 109919 [PMID: 41278450 DOI: 10.4239/wjd.v16.i11.109919]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.